Cooper Galvin

Dr. Cooper Galvin is an Alaskan biophysicist, entrepreneur, and investor who builds at the intersection of molecular science and population health. He has founded companies across radically different funding models: a nonprofit that has sustained itself for more than a decade, and venture-backed startups through which he has raised multiple multimillion-dollar rounds. He advises founders that capital is not one-size-fits-all, and has developed heuristics for matching the founder, industry, speed, and type of capital.

He is the co-founder of Endless Health, a US health-tech company building wrap-around preventive care, and of EndlessDX, a blood-testing platform designed to make diagnostics radically more accessible. Earlier, he founded Future Advancers of Science and Technology (FAST), the San Francisco Bay Area’s most extensive STEM outreach program for low-income high-school students. As an active investor and operator in US health-tech and biotech, he weighs when speed is an advantage and when it’s a trap.

Dr. Galvin holds a PhD in Molecular Biophysics and an MS in Bioengineering from Stanford. He was previously an Associate at McKinsey & Company and a post-doctoral researcher in population health in Taiwan and the United States.